Approval · Notice of Compliance 944 · 2000
KIDROLASE: Notice of Compliance 944
Issued October 10, 2000
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 944
- Date
- October 10, 2000
- Company
- Aventis Pharma Inc.Laval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Antileukemic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| KIDROLASE | 01926438 | Cancelled Post Market |
Medicinal ingredients
- ASPARAGINASE 10,000 UNIT per VIAL